[Vitamin E in the treatment of pregnancy complicated by uterine myoma].
The authors describe the encouraging results obtained in the treatment of uterine myomas during pregnancy, using vitamin E at a dose of 300 mg times a day, starting the administration from the time of the first examination of the patient, which took place between week 6 and 12 of gestation. A group of 25 women underwent treatment, aged between 25 and 41 years old, of whom 15 were primigravidas and 10 with one or more previous pregnancies, suffering from uterine myomas in pregnancy, and observed between 1986 and 1994. All the pregnancies continued to term and elective cesarean section was performed associated with single or multiple myomectomy. The neonatal outcome was satisfactory in all cases and no collateral effects were observed in either mothers or fetuses.
Fruscella
L
L
Divisione di Ostetricia e Ginecologia, USL RM/B, Ospedale S. Pertini, Roma.
Ciaglia
E M
EM
Danti
M
M
Fiumara
D
D
D000328:Adult; D002585:Cesarean Section; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007889:Leiomyoma / Q000188:drug therapy* / Q000601:surgery; D008297:Male; D010298:Parity; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000188:drug therapy* / Q000601:surgery; D013997:Time Factors; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000601:surgery; D014810:Vitamin E / Q000008:administration & dosage / Q000627:therapeutic use*
D014810:Vitamin E